Medicsight signs Spanish IT company

Article

Other headlines: Medicsight signs Spanish IT company

Medicsight signs Spanish IT company


Computer-aided detection specialist Medicsight has signed a non-exclusive, software license and distribution agreement with Spain-based Alma IT Systems. As part of this agreement, Alma will integrate Medicsight's ColonCAD API 4.0 software into its latest Colon viewer for sale across Europe and South America. The viewer is a 3D visualization workstation designed to help interprets CT colonography images.

IMIX places new DR product

IMIX Americas has installed the first of its new digital radiography product, IMIXhorizon SomaRad, a value-oriented DR system. The company is marketing the system especially to small hospitals, imaging centers, and orthopedic practices. Launched at the 2008 RSNA meeting, SomaRad has been installed at facilities including Centrelake Imaging & Oncology in Covina, CA; the Minnesota private practice of Dr. John Stark in Minneapolis; Lake Station Center in Lake Station, IN; and North Shore Health Centers, Portage, IN.
 

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.